Three out of 36 neuroblastoma patients (8%) carried germline pathogenic variants in NF1, BRCA1, and PTCH1. Germline pathogenic variants in NF1 have been described previously in neuroblastoma patients13,14. This evidence concerns the gene PTCH1 and neuroblastoma.